Asia Pacific medical device market will grow by 8.4% annually with a total addressable market cap of $2.06 trillion over 2023-2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insurance.
Highlighted with 102 tables and 70 figures, this 207-page report “Asia Pacific Medical Device Market 2022-2032 by Category (Diagnostic, Consumables, Patient Aids, Orthopaedics, Dental, Others), Application (Imaging, IVDs, Cardiology, Orthopedics, Ophthalmics, Respiratory), End User (Hospitals, Clinics, Household), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific medical device market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces


The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Ukraine-Russia conflict. The balanced (most likely) projection is used to quantify Asia Pacific medical device market in every aspect of the classification from perspectives of Category, Application, End User, and Country.

Based on Category, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2022-2032 included in each section.

  • Diagnostic Devices


o Electrodiagnostic Devices (further segmented into Ultrasound Systems, Magnetic Resonance Imaging (MRI), Electrocardiographs, Scintigraphic Apparatus, Other Electrodiagnostic Devices)
o Radiation Devices (further segmented into CT Scanners; Other Medical X-ray Apparatus; A, B, C Ray Apparatus)
o Imaging Parts & Accessories (further segmented into Contrast Media, X-ray Tubes, Medical X-ray Film, Other Imaging Parts & Accessories)

  • Consumables


o Syringes, Needles & Catheters (further segmented into Syringes (with/without needles), Tubular Metal Needles/Needles for Sutures, Others)
o Bandages & Dressings (further segmented into Adhesive Medical Dressings and Non-adhesive Medical Dressings)
o Suturing Materials
o Other Consumables (further segmented into Surgical Gloves, Ostomy Products, Blood-Grouping Reagents, First-aid Boxes & Kits)

  • Patient Aids


o Portable Aids (further segmented into Hearing Aids, Pacemakers, Other Portable Aids)
o Therapeutic Applications (further segmented into Therapeutic Respiration Devices and Mechano-Therapy Devices)

  • Orthopaedics and Prosthetics


o Fixation Devices
o Artificial Joints
o Other Artificial Body Parts

  • Dental Products


o Dental Instrument & Supplies (further segmented into Dental Instruments, Dental Cements, Teeth & Other Fittings)
o Dental Capital Equipment (further segmented into Dental Drills, Dental Chairs, Dental X-ray)

  • Other Medical Device Categories


o Ophthalmic Instruments
o Hospital Furniture
o Wheelchairs
o Medical & Surgical Sterilisers
o Ultra-violet or Infra-red Ray Apparatus
o Other Instruments & Appliances

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2022-2032 included in each section.

  • Diagnostic Imaging Devices
  • In Vitro Diagnostics (IVDs)
  • Cardiology
  • Orthopedics
  • Ophthalmics
  • Respiratory
  • Urology & Gynecology
  • General and Plastic Surgery
  • Endoscopy
  • Dental
  • Diabetic Care
  • Wound Management
  • Nephrology
  • General Hospital and Healthcare
  • Ear, Nose and Throat
  • Neurology
  • Robotics Navigation
  • Other Applications



Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2022-2032 included in each section.

  • Hospitals & Surgical Centers
  • Clinics
  • Household
  • Other End Users



Geographically, the following national/local markets are fully investigated:

  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)


For each key country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Application and End User over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
3M Co.
Abbott Laboratories
Allergan Inc.
Baxter International Inc.
Bayer
Becton, Dickinson and Co.
Boston Scientific Corp.
Cardinal Health Inc.
Covidien plc
Cryolife Inc.
Danaher
Depuy Synthes
Endologix, Inc.
Essilor International SA
Fresenius Medical Care AG & Co. KGAA
GE Healthcare
Getinge Ab
Johnson & Johnson
Koninklijke Philips NV
Medtronic Inc.
Novartis AG
Olympus Corp.
Roche Diagnostics
Siemens Healthcare
Smith & Nephew PLC
Smiths Medical
St. Jude Medical Inc.
Stryker Corp.
Terumo Corp.
Thermo Fisher Scientific
Zimmer Holdings Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)